Binding of [35S]GTPγS stimulated by (+)-pentazocine, sigma receptor agonist, is abundant in the guinea pig spleen

Life Sciences

Volumn 67, Issue 5, 2000, Pages 599-603

  Maruo, Junko ^a,b   Yoshida, Akira ^a   Shimohira, Ichiro ^a   Matsuno, Kiyoshi ^b   Mita, Shiro ^b   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

35S GTP S binding; G protein; Metabotropic sigma receptor; Spleen

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PENTAZOCINE; SIGMA OPIATE RECEPTOR; SULFUR;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CONTROLLED STUDY; GUINEA PIG; MALE; MOUSE; NONHUMAN; SPLEEN; ANIMAL; DRUG POTENTIATION; LIVER; LUNG; METABOLISM; TESTIS;

ANIMALS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUINEA PIGS; LIVER; LUNG; MALE; MICE; PENTAZOCINE; RECEPTORS, SIGMA; SPLEEN; SULFUR RADIOISOTOPES; TESTIS;

EID: 0034705235     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00651-2     Document Type: Article

References (20)

1. R. Quirion, W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.P. Su, S.W. Tam and D.P. Taylor, Trends Pharmacol. Sci. 13 85-86 (1992).
2. Y. Itzhak, Mol. Pharmacol. 36 512-517 (1989).
3. J.H. Connick, G. Hanlon, J. Roberts, L. France, P.K. Fox and C.D. Nicholson, Br. J. Pharmacol. 107 726-731 (1992).
4. S. Tokuyama, K. Hirata, A. Yoshida, J. Maruo, K. Matsuno, S. Mita and H. Ueda, NeuroSci. Lett. 268 85-88 (1999).
5. S. Tokuyama, K. Hirata, A. Ide and H. Ueda, Neurosci. Lett. 233 141-144 (1997).
6. K. Kakizawa, I. Shimohira, S. Sakurada, T. Fujimura, K. Murayama and H. Ueda, PepTides 19 755-758 (1998).
7. I. Shimohira, S. Tokuyama, A. Himeno, M. Niwa and H. Ueda, Neurosci. Lett. 237 113-116 (1997).
8. K.J. Kovács and A.A. Larson, Eur. J. Pharmacol. 285 127-134 (1995).
9. N.N. Samovilova, L.V. Nagornaya and V.A. Vinogradov, Eur. J. Pharmacol. 147 259-264 (1988).
10. S.A. Wolfe, Jr., S.G. Culp and E.B. De Souza, Endocrinology 124 1160-1172 (1989).
11. K. Matsuno, T. Senda and S. Mita, Eur. J. Pharmacol. 231 451-457 (1993).
12. S. Okuyama and A. Nakazato, CNS Drug Reviews 2 226-237 (1996).
13. P.M. Beart, R.D. O'Shea and D.T. Manallack, J. Neurochem. 53 779-788 (1989).
14. Y. Itzhak and I. Stein, Brain Res. 566 166-172 (1991).
15. F.P. Monnet, G. Debonnel, R. Bergeron, B. Gronier and C. De Montigny, Br. J. Pharmacol. 112 709-715 (1994).
16. M. Hanner, F.F. Moebius, A. Flandorfer, H.G. Knaus, J. Striessnig, E. Kempner and H. Glossmann, Proc. Natl. Acad. Sci. USA 93 8072-8077 (1996).
17. H. Ueda, S. Tokuyama, H. Nomura, K. Hirata, A. Yoshida, J. Maruo, K. Matsuno and S. Mita, Soc. Neurosci. Abstr. 24 1594 (1998).
18. S.A. Wolfe, Jr., B.K. Ha, B.B. Whitlock and P. Saini, J. Neuroimmunol. 72 45-58 (1997).
19. R. Maity, R. Mukherjee and P. Skolnick, J. Neuroimmunol. 70 7-13 (1996).
20. C. Song, B.E. Leonard, Eur. J. Pharmacol. 345 79-87 (1998).